Hologic Inc.

Company Overview

Hologic Inc. develops, manufactures, and supplies high-quality diagnostic products, medical imaging systems, and surgical solutions, with a focus on women’s health and well-being through early detection and treatment. It operates in four segments: diagnostics, breast health, GYN surgical, and skeletal health.

In the field of noninvasive cancer diagnostics, Hologic leverages its advanced molecular and cytology-based testing platforms to enable early detection and screening of cancers, particularly cervical and breast cancers. Its flagship diagnostic technologies include the Panther system and Aptima assays, which provide high-throughput, automated molecular testing capabilities that support accurate and efficient cancer screening workflows in laboratories worldwide.

Hologic Inc.’s innovations extend to liquid biopsy and molecular cytology, which aim to enhance early cancer detection through minimally invasive sampling. By integrating AI-driven imaging analytics and molecular diagnostic tools, it continues to strengthen its position in precision oncology diagnostics. Its strong global footprint, partnerships, and focus on women-centered cancer detection make it a significant player in the noninvasive cancer diagnostics market.

Financial Highlights (FY 2025)

Company's Business Segments

• Diagnostics : Cytology & Perinatal, Molecular Diagnostics, Blood Screening
• Breast Health : Breast Imaging, Interventional Breast Solutions
• GYN Surgical : Myosure Hysteroscopic Tissue Removal System, Novasure Endometrial Ablation System, Fluent Fluid Management System, Acessa Provu Laparoscopic Radiofrequency Ablation System, Coolseal Vessel Sealing Portfolio, Justright Surgical Stapler
• Skeletal Health : Horizon DXA, Fluoroscan Insight FD mini C-arm